Facebook Pixel Code
The Hospital for Sick Children

Fellowship Program

The Division of Endocrinology is accredited by the Royal College of Physicians and Surgeons of Canada for the training of individuals interested in pursuing a career in Paediatric Endocrinology.

All activities of the Division are located at The Hospital for Sick Children. Training of fellows involves an initial clinical year, followed by an additional year of training in clinical endocrinology, clinical research, basic research or education research tailored to the trainee’s career goals.

Clinical Activities:

A. Diabetes Service

  • Provides care for 1000 children and adolescents with diabetes mellitus
  • 170 new referrals annually
  • Care of these children takes place in the context of a large multidisciplinary team: endocrinologists, diabetes nurse educators, clinical nurse specialist, dieticians, and social workers, with three diabetes clinics each week (4000 annual visits), and a weekly diabetes team meeting
  • In-hospital consultations are performed for diabetes-related problems such as emergency room consultation, cystic fibrosis-related diabetes, steroid-induced diabetes, surgery on children with diabetes
  • The diabetes team offers a 24 hours/day hot-line consultation service for those children and their families who are followed by our diabetes service

B. Endocrinology

  • The Endocrine Division follows children with all types of endocrine disorders
  • There are four general endocrinology clinics per week.
  • There are six specialized clinics that occur regularly: Calcium Disorders, Bone Health, Disorders of Sex Development, Young Women’s Reproductive Health (in conjunction with Gynaecology), Late Effects of Cancer Therapy, and Complex Obesity
  • 5600 annual visits clinic visits with 650 new referrals
  • In-hospital consultations are performed for a wide variety of conditions

Research Endeavors: 

Primary research activities in the Division of Endocrinology are in the area of clinical investigation.  Current research carried out by division faculty members includes studies of:

  • Prevention of beta cell loss in those at risk of Type 1 diabetes and in new onset disease through the NIH Type 1 Diabetes TrialNet Study Group
  • Outcomes in children with disorders of sex development
  • Understanding the early pathophysiology of diabetic nephropathy in adolescents with Type 1 diabetes
  • Calcium disorders in neonates, the role of Vitamin D in pathogenesis of diabetes complications, and the management of osteoporosis among children and youth
  • Diabetes complications including celiac disease in Type 1 diabetes as well as the evaluation of early atherosclerosis in young patients with endocrine conditions who are at high risk of cardiovascular disease including, obesity and Type 1 and Type 2 diabetes
  • Prevention of long term micro and macrovascular complications of Type 1 diabetes in the pediatric population. Current research includes: i) the identification adolescents with Type 1 diabetes at high risk of developing complications based on urinary albumin excretion rates and ii) a randomized placebo controlled trial looking at the potential of early initiation of lipid lowering agents and angiotensin converting enzyme inhibitors to prevent long term cardio and renal complications in this high risk population (AdDIT)
  • Evaluation of the effectiveness and optimal timing of initiating continuous glucose monitoring in pediatric Type 1 diabetes insulin pump users
  • Evaluation and treatment of infants with hypoglycemia, particularly those with congenital hyerperinsulinism
  • Insulin resistance and pancreatic beta cell function and the metabolic complications of obesity in childhood, specific populations of children known to be at risk for future cardiometabolic disease (e.g. Turner Syndrome, hypothalamic obesity related to central nervous brain system tumours such as craniopharyngioma, infants exposed to hyperglycemia in utero, Type 2 diabetes
  • Understanding variations in the timing and pace of pubertal development using a combination of clinical research and an active laboratory-based program designed to identify and study genetic factors that modulate the timing of puberty
  • Improving treatment outcomes in Types 1 and 2 diabetes

Academic Activities:

Weekly activities in the Division include:

  • Twice endocrinology rounds/case presentations/journal club
  • City-wide Endocrinology rounds in conjunction with Division of Endocrinology in the Department of Medicine, University of Toronto
  • Weekly Academic Half Day in endocrinology in conjunction with the adult Endocrinology Subspecialty Training Program at the University of Toronto
  • Weekly paediatric endocrinology fellow seminar series

Goals and Objectives:

See goals and objectives

Application Procedures:

The application session has closed for the academic year starting July 1, 2021.

For those wishing to commence training on July 1, 2022, please apply before August 1, 2021. **The online application opens December 2020** 

*Canadians apply through CARMS*

To apply to the program, please submit your fellowship application through our online form and include the following attachments:

  • Current Curriculum Vitae
  • Copy of Medical Degree
  • Academic Transcripts (undergraduate and postgraduate)
  • Copy of Paediatrics Specialty Certificate (if you are currently a Paediatric trainee, please arrange for your Program Director to provide us with a letter of good standing)
  • Letter of Intent describing your interest in endocrinology and career interests

In addition, please ask three individuals who know you well to send confidential letters in support of your application to endo.program@sickkids.ca. One letter should come from your residency program director. Your referees should comment upon your interpersonal skills, clinical skills and provide us with some insights regarding your background or potential for research. 

Applicants will need to have completed pediatric training by the time fellowship training begins.

To all applicants:

If you have applied to the U.S Match through the National Residency Matching Program (NRMP), please be advised that the University of Toronto is a participating institution and adheres to the match policy. The policy states that "applicants who have matched to a program or have accepted a position during the Supplemental Offer and Acceptance Program (SOAP), shall not apply for, discuss, interview for, or accept a concurrent year position in another program prior to the NRMP granting the requested waiver."